Overview
Lutein is an xanthophyll and one of 600 known naturally occurring carotenoids. Lutein is synthesized only by plants and like other xanthophylls is found in high quantities in green leafy vegetables such as spinach, kale and yellow carrots. In green plants, xanthophylls act to modulate light energy and serve as non-photochemical quenching agents to deal with triplet chlorophyll (an excited form of chlorophyll), which is overproduced at very high light levels, during photosynthesis.
Indication
Xanthophylls are taken for nutritional supplementation, and also for treating dietary shortage or imbalance.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2010/01/26 | Phase 1 | UNKNOWN | Peking University | ||
2010/01/13 | Phase 1 | UNKNOWN | Peking University | ||
2007/03/21 | Phase 4 | Completed | |||
2006/06/29 | Phase 3 | Completed | |||
2005/07/21 | Phase 1 | Completed | |||
2002/01/10 | Phase 1 | Completed | |||
2000/09/11 | Phase 2 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Exeltis USA, Inc. | 0642-0207 | ORAL | 5 mg in 1 1 | 1/2/2023 | |
Adler-Stern Pharmaceuticals, LLC | 69054-210 | ORAL | 10 mg in 1 1 | 11/7/2014 | |
Adler-Stern Pharmaceuticals, LLC | 69054-211 | ORAL | 5 mg in 1 1 | 12/2/2014 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
Macutec Essentials | 326524 | Medicine | A | 11/22/2019 | |
Kids Multi | 329564 | Medicine | A | 2/6/2020 | |
BLACKMORES MACU-VISION PLUS | 317969 | Medicine | A | 5/28/2019 | |
NUTRA-LIFE BILBERRY 10,000 PLUS | 310442 | Medicine | A | 10/17/2018 | |
Swisse Men's Multivitamins | 351919 | Medicine | A | 12/18/2020 | |
USANA HealthPak | 350153 | Medicine | A | 11/30/2020 | |
Daily Multi Multivitamin | 337216 | Medicine | A | 5/29/2020 | |
HK-SG Swisse Kids Eye Health | 349251 | Medicine | A | 11/23/2020 | |
Eye Vita Plus | 379094 | Medicine | A | 11/26/2021 | |
Optimal Omega + | 396614 | Medicine | A | 9/28/2022 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
No CIMA AEMPS (Spain) approvals found for this drug. |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.